Sarcomatoid Mesothelioma
specificA malignant neoplasm arising from mesothelial cells. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen.
17
Centers
14
Active Trials
—
Cancer Funding
Top Centers for Sarcomatoid Mesothelioma(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 56.9 |
| 2 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 56.9 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 56.9 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 56.9 |
| 5 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 56.9 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 56.9 |
| 7 | NCI Clinical Active Research Program | 56.9 |
| 8 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 56.9 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 56.9 |
| 10 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 56.9 |
| 11 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 56.9 |
| 12 | Active Research Program | 56.9 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 56.9 |
| 14 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 56.9 |
| 15 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 34.4 |
| 16 | NCI Comprehensive | 34.4 |
| 17 | Penn State Cancer InstituteHershey, PA | 34.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →